Russia's Nanolek aims to be largest supplier of drugs for state needs this year

Russian drugmaker Nanolek is aiming to become the largest supplier of drugs for state needs this year, The Pharma Letter’s local correspondent reports.

As part of these plans, in the first half of 2023 the company increased the supply of drugs under the state order by 2.7-fold, to 16.61 billion roubles ($180.5 million), taking the third place due to the expansion of the range.

According to analysts, the first place was retained by Pharmstandard with 38.34 billion roubles, while R-Pharm was the second with 27.12 billion roubles.